The EIR was issued post the last inspection of the facility conducted from May 6-10, 2024 which concluded with zero FDA 483 observations
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Shivani Satish Wagh takes on the role of Joint Managing Director
The facility is a part of Lupin Manufacturing Solutions
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Subscribe To Our Newsletter & Stay Updated
